Braltus (tiotropium bromide) / Teva - LARVOL DELTA

ANTES B+ Clinical Trial (clinicaltrials.gov) - P4 | N=48 | Terminated | Sponsor: Fundacio Privada Mon Clinic Barcelona | N=1028 ➔ 48 | Trial completion date: Sep 2025 ➔ Jan 2025 | Recruiting ➔ Terminated | Trial primary completion date: Sep 2025 ➔ Jan 2025; Delays in the opening and activation of participating sites, and a low recruitment rate, with only 48 participants enrolled over the course of one year

Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases

ANTES B+ Clinical Trial (clinicaltrials.gov) - P4 | N=1028 | Recruiting | Sponsor: Fundacio Privada Mon Clinic Barcelona | Not yet recruiting ➔ Recruiting

Enrollment open • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases

ANTES B+ Clinical Trial (clinicaltrials.gov) - P4 | N=1028 | Not yet recruiting | Sponsor: Fundacio Privada Mon Clinic Barcelona

New P4 trial • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases

Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements. (PubMed, Pharmaceuticals (Basel)) - "Additionally, the morphology and stability of 3 DPI capsules (Spiriva, Braltus, and Onbrez) were investigated, offering valuable insights into the properties of these formulations. Altogether, these findings contribute to a deeper understanding of DPIs and their development, performance, and optimization of inhalation dosage forms."

Journal • Review

"Switches LAMA/LABA/ICS➡️Trimbow LAMA/LABA➡️Duaklir Genuair/Spiolto Respimat/Bevespi Aerosphere LABA/ICS➡️Fostair/Symbicort/DuoResp Spiromax etc LAMA➡️Spiriva/Braltus etc @GSK please find Ellipta alternative so we can use your once daily drugs @Novartis pls replace Breezhaler 3/" (@DrHugoA)

Inhaled long-acting bronchodilators with or without inhaled glucocorticosteroids for preventing hospitalizations and death in elderly patients with chronic obstructive pulmonary disease. Broncodilatatori inalatori a lunga durata d’ azione con o senza glucocorticosteroidi inalatori nella prevenzione della re-ospedalizzazione e/o della mortalità in pazienti anziani affetti da malattia cronica... (clinicaltrialsregister.eu) - P4; N=1032; Ongoing; Sponsor: AZIENDA OSPEDALIERO UNIVERSITARIA DI FERRARA

Clinical • New P4 trial • Chronic Obstructive Pulmonary Disease • Immunology • Inflammation • Respiratory Diseases